Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-04 (Itraconazole) Ointment in Rosacea
NCT02828241Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Jul 2016
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of itraconazole in papulopustular rosacea (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoints: Change in Inflammatory Lesion Counts at 12 weeks, Number of Subjects With Investigator's Global Assessment (IGA) Success at 12 weeks and 1 more. Started Jul 2016; status: completed.
02
Drugs
itraconazole
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02828241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02828241.